Humm Group (ASX:HUM) - Independent Chair, Christine Christian
Independent Chair, Christine Christian
Source: Humm Grup
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Humm Group (HUM) has received expressions of interest from third parties to acquire a portion of the company
  • Humm says it intends to investigate these approaches to determine whether they are capable of becoming definitive offers
  • Meanwhile, Humm’s Chair Andrew Abercrombie announced he will step down from his role
  • Following the resignation, Christine Christian has been appointed as Independent Chair of Humm Group
  • HUM jumped 18.2 per cent, trading at 87.5 cents

Humm Group (HUM) shares have soared following expressions of interest from third parties to acquire a portion of the company.  

The buy now, pay later business intends to investigate these approaches to determine whether they’re capable of becoming definitive offers.

As yet, the company said there were no assurances that any transaction will occur.

Meanwhile, Humm’s Chair Andrew Abercrombie has announced he will step down from the role.

Following the resignation, Christine Christian has been appointed as Independent Chair.

“On behalf of my fellow directors I thank Andrew for his service and his counsel as Chairman of the Group,” she said.

“I look forward to working with my fellow directors to assess the proposals put before us and importantly, to support the management team as they implement the company’s strategy to grow the business profitably.”

Mr Abercrombie was a founding shareholder of the original FlexiRent business and Humm Group said it would continue to benefit from his insights and corporate knowledge.

Following today’s leadership and acquisition news, Humm Group jumped 18.2 per cent, trading at 87.5 cents at 1:22 pm AEDT.

HUM by the numbers
More From The Market Herald

" PointsBet (ASX:PBH) losses extend to $51.8m

PointsBet (ASX:PBH) has reported $51.8 million in cash outflows for its quarterly update as the company…
Imugene (ASX:IMU) - CEO, Leslie Chong

" Imugene (ASX:IMU) signs clinical trial agreement with Roche for lung cancer

Imugene (ASX:IMU) signs a clinical trial supply agreement with Roche to evaluate the combination of treatments…
Fiji Kava (ASZ:FIJ) - CEO and Managing Director, Dr Anthony Noble

" Fiji Kava (ASX:FIJ) hits quarterly revenue record

Fiji Kava (ASX:FIJ) has tabled a record quarterly revenue of $476,531 for the December quarter, up…
Imagion Biosystems (ASX:IBX) - CEO & Executive Chairman, Bob Proulx

" Imagion (ASX:IBX) ends 2021 on an “upbeat note”

Imagion Biosytems (ASX:IBX) finishes 2021 on an "upbeat note" as it progresses with its MagSense HER2…